OB
Oisin Biotechnologies
AgeTech
About
Oisin Biotechnologies develops senolytic therapies designed to selectively eliminate senescent cells that accumulate with age and contribute to age-related diseases. The company's platform technology aims to address underlying biological causes of aging through targeted cellular interventions.
Is this your company?
Claim this listing to update your profile, add your logo, and reach buyers searching for AgeTech.
Key facts
Are you Oisin Biotechnologies?
Claim your profile
Upgrade to Premium for a full profile, featured badge, logo, and contact button.
Get premium listing →